ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
June 01, 2022 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...